Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Magyari

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Multiple Sclerosis and Related Disorders|January 12, 2018
Disability in progressive MS is associated with T2 lesion changesC Ammitzbøll, T B Dyrby, M Lyksborg, et al.
Multiple Sclerosis and Related Disorders|July 7, 2023
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosisC Ammitzbøll, T B Dyrby, L Börnsen, et al.
Journal of Neurology|November 8, 2025
Big multiple sclerosis data network: novel modelling approaches for real-world data analysisM Trojano, P Iaffaldano, M Copetti, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint studyG Saposnik, S Andhavarapu, Ó Fernández, et al.
European Journal of Neurology|August 30, 2019
A population-based epidemiological study of neuromyelitis optica spectrum disorder in HungaryV Papp, A Iljicsov, C Rajda, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Multiple Sclerosis and Related Disorders|January 12, 2018
Disability in progressive MS is associated with T2 lesion changesC Ammitzbøll, T B Dyrby, M Lyksborg, et al.
Multiple Sclerosis and Related Disorders|July 7, 2023
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosisC Ammitzbøll, T B Dyrby, L Börnsen, et al.
Journal of Neurology|November 8, 2025
Big multiple sclerosis data network: novel modelling approaches for real-world data analysisM Trojano, P Iaffaldano, M Copetti, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint studyG Saposnik, S Andhavarapu, Ó Fernández, et al.
European Journal of Neurology|August 30, 2019
A population-based epidemiological study of neuromyelitis optica spectrum disorder in HungaryV Papp, A Iljicsov, C Rajda, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 4